Enterprise Value
1.325M
Cash
4.429M
Avg Qtr Burn
-5.698M
Short % of Float
6.88%
Insider Ownership
0.00%
Institutional Own.
3.54%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Twirla (levonorgestrel and ethinyl estradiol) transdermal system Details Contraception By Women Of Reproductive Potential With A Body Mass Index (Bmi) < 30 Kg/m2 | Approved Quarterly sales | |
AG890 Details Contraceptive, Progestin-only contraception | Phase 2 Update |